Please provide your email address to receive an email when new articles are posted on . Two different doses of CC-90001 vs. placebo slowed decline of percentage of predicted FVC at week 24.
Please provide your email address to receive an email when new articles are posted on . Adverse events reported with ENV-101 have been seen with other hedgehog inhibitors. Another trial is already ...
Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...
Proton pump inhibitors (PPIs) were strongly linked with serious infection risk among infants and young children in a large national study, suggesting caution in prescribing. In more than one million ...
(MENAFN- EIN Presswire) EINPresswire/ -- The respiratory syncytial virus (RSV) fusion inhibitors market is experiencing significant momentum as advancements in healthcare and increasing respiratory ...
Medpage Today on MSN
Do TNF Inhibitors Really Worsen RA-Associated Lung Disease?
Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications ...
In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback